{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T09:40:48Z","timestamp":1770284448931,"version":"3.49.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Cholestasis in infants can indicate a serious hepatobiliary disease and requires timely assessment, diagnosis and intervention to prevent progression to serious liver decompensation. This report aims to highlight recently published studies regarding diagnosis and treatment of cholestasis in infants.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>The evaluation of neonatal cholestasis can be challenging, requiring the assessment of a broad differential diagnosis in timely fashion. The Italian Society of pediatric gastroenterology, hepatology, and nutrition position paper on the evaluation of neonatal cholestasis is reviewed and compared to other published guidelines. In biliary atresia, the most time-sensitive of these diagnoses, serum matrix metalloproteinase-7 was studied in Japanese infants with biliary atresia with excellent diagnostic performance characteristics. Genetic testing panels are an increasingly used tool to help identify causes of cholestasis. An American experience of genetic testing in large cohort of infants identified a definite or possible genetic diagnosis in 11% of cholestatic infants. In the treatment of prutitus in Alagille syndrome and progressive familial intrahepatic cholestasis the clinical studies of two newly Food and Drug Administration approved ileal bile acid transport inhibitors are discussed. New information on the prevalence of cytomegalovirus and idiopathic cholestasis as other etiologies of infant cholestasis is also reviewed. Lastly, new insight on potential maternal microbiome regulation on biliary disease in neonates on experimental biliary atresia models is discussed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Cholestasis in infants requires timely diagnosis and intervention. There are exciting new diagnostic and treatment options now being studied which could help minimize the likelihood of advanced liver disease and development of serious complications.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000001156","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T04:01:42Z","timestamp":1660017702000},"page":"491-495","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["The cholestatic infant: updates on diagnosis and genetics"],"prefix":"10.1097","volume":"34","author":[{"given":"Andrew","family":"Wehrman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"R1-20250730","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/MPG.0000000000001334","article-title":"Guideline for the Evaluation of Cholestatic Jaundice in Infants: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition","volume":"64","author":"Fawaz","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R2-20250730","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.dld.2021.09.011","article-title":"Diagnostic approach to neonatal and infantile cholestasis: a position paper by the SIGENP liver disease working group","volume":"54","author":"Ranucci","year":"2022","journal-title":"Dig Liver Dis"},{"key":"R3-20250730","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00595-014-1024-z","article-title":"Effects of age at Kasai portoenterostomy on the surgical outcome: a review of the literature","volume":"45","author":"Nio","year":"2015","journal-title":"Surg Today"},{"key":"R4-20250730","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/jama.2020.0837","article-title":"Diagnostic yield of newborn screening for biliary atresia using direct or conjugated bilirubin measurements","volume":"323","author":"Harpavat","year":"2020","journal-title":"JAMA"},{"key":"R5-20250730","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1097\/PAS.0000000000000755","article-title":"Key histopathologic features of liver biopsies that distinguish biliary atresia from other causes of infantile cholestasis and their correlation with outcome: a multicenter study","volume":"40","author":"Russo","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R6-20250730","doi-asserted-by":"crossref","first-page":"eaan8462","DOI":"10.1126\/scitranslmed.aan8462","article-title":"Large-scale proteomics identifies MMP-7 as a sentinel of epithelial injury and of biliary atresia","volume":"9","author":"Lertudomphonwanit","year":"2017","journal-title":"Sci Transl Med"},{"key":"R7-20250730","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1002\/hep.30234","article-title":"Diagnostic accuracy of serum matrix metalloproteinase-7 for biliary atresia","volume":"68","author":"Yang","year":"2018","journal-title":"Hepatology"},{"key":"R8-20250730","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/hepr.13753","article-title":"Serum matrix metalloproteinase-7 in biliary atresia: a Japanese multicenter study","volume":"52","author":"Sakaguchi","year":"2022","journal-title":"Hepatol Res"},{"key":"R9-20250730","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.3390\/genes12111837","article-title":"The genetics of inherited cholestatic disorders in neonates and infants: evolving challenges","volume":"12","author":"Jeyaraj","year":"2021","journal-title":"Genes (Basel)"},{"key":"R10-20250730","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/MPG.0000000000003094","article-title":"Use of a comprehensive 66-gene cholestasis sequencing panel in 2171 cholestatic infants, children, and young adults","volume":"72","author":"Karpen","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R11-20250730","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s12072-020-10070-w","article-title":"Ileal bile acid transporter inhibition as an anticholestatic therapeutic target in biliary atresia and other cholestatic disorders","volume":"14","author":"Karpen","year":"2020","journal-title":"Hepatol Int"},{"key":"R12-20250730","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/S0140-6736(21)01256-3","article-title":"Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study","volume":"398","author":"Gonzales","year":"2021","journal-title":"Lancet"},{"key":"R13-20250730","doi-asserted-by":"crossref","first-page":"101751","DOI":"10.1016\/j.clinre.2021.101751","article-title":"Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study","volume":"45","author":"Baumann","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R15-20250730","doi-asserted-by":"crossref","DOI":"10.1002\/hep4.1980","article-title":"Maralixibat for the treatment of PFIC: long-term, IBAT inhibition in an open-label, Phase 2 study","author":"Loomes","year":"2022","journal-title":"Hepatol Commun"},{"key":"R16-20250730","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3390\/jcm11040945","article-title":"Incidence, impact and treatment of ongoing CMV infection in patients with biliary atresia in four European centres","volume":"11","author":"Fischler","year":"2022","journal-title":"J Clin Med"},{"key":"R17-20250730","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/MPG.0000000000003248","article-title":"Presentation and outcomes of infants with idiopathic cholestasis: a multicenter prospective study","volume":"73","author":"Hertel","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R18-20250730","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41467-021-27689-4","article-title":"Maternal regulation of biliary disease in neonates via gut microbial metabolites","volume":"13","author":"Jee","year":"2022","journal-title":"Nat Commun"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T18:01:56Z","timestamp":1753898516000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001156","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,3]]}}}